138 related articles for article (PubMed ID: 34667073)
1.
Hong CS; Khan M; Sukys JM; Prasad M; Erson-Omay EZ; Vining EM; Omay SB
Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 34667073
[TBL] [Abstract][Full Text] [Related]
2. β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma).
Suzuki Y; Ichihara S; Kawasaki T; Yanai H; Kitagawa S; Shimoyama Y; Nakamura S; Nakaguro M
Virchows Arch; 2018 Aug; 473(2):235-239. PubMed ID: 29736797
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.
Lasota J; Felisiak-Golabek A; Aly FZ; Wang ZF; Thompson LD; Miettinen M
Mod Pathol; 2015 May; 28(5):715-20. PubMed ID: 25431235
[TBL] [Abstract][Full Text] [Related]
4. Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
Park YL; Kim HP; Cho YW; Min DW; Cheon SK; Lim YJ; Song SH; Kim SJ; Han SW; Park KJ; Kim TY
Int J Cancer; 2019 Jan; 144(2):389-401. PubMed ID: 29978469
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Merino VF; Cho S; Liang X; Park S; Jin K; Chen Q; Pan D; Zahnow CA; Rein AR; Sukumar S
Mol Oncol; 2017 May; 11(5):552-566. PubMed ID: 28296140
[TBL] [Abstract][Full Text] [Related]
6. CTNNB1 mutations in basal cell adenoma of the salivary gland.
Lee YH; Huang WC; Hsieh MS
J Formos Med Assoc; 2018 Oct; 117(10):894-901. PubMed ID: 29224720
[TBL] [Abstract][Full Text] [Related]
7. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
[TBL] [Abstract][Full Text] [Related]
8. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.
Byron SA; Gartside M; Powell MA; Wellens CL; Gao F; Mutch DG; Goodfellow PJ; Pollock PM
PLoS One; 2012; 7(2):e30801. PubMed ID: 22383975
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
[TBL] [Abstract][Full Text] [Related]
10. Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review.
Kono M; Bandoh N; Matsuoka R; Goto T; Akahane T; Kato Y; Nakano H; Yamaguchi T; Harabuchi Y; Nishihara H
Head Neck Pathol; 2019 Sep; 13(3):298-303. PubMed ID: 30206803
[TBL] [Abstract][Full Text] [Related]
11. CD34-Positive Spindle Cell Tumor With
Iwamura R; Nawata A; Akaike R; Kitamura T; Hisaoka M
Int J Surg Pathol; 2024 Apr; 32(2):408-413. PubMed ID: 37287277
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.
He J; Zeng Z; Wang Y; Deng J; Tang X; Liu F; Huang J; Chen H; Liang R; Zan X; Liu Z; Tong A; Guo G; Xu J; Zhu X; Zhou L; Peng Y
Mol Cancer; 2021 Dec; 20(1):168. PubMed ID: 34922552
[TBL] [Abstract][Full Text] [Related]
13. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA Mutational Status Is Associated with High Glycolytic Activity in ER+/HER2- Early Invasive Breast Cancer: a Molecular Imaging Study Using [
Magometschnigg H; Pinker K; Helbich T; Brandstetter A; Rudas M; Nakuz T; Baltzer P; Wadsak W; Hacker M; Weber M; Dubsky P; Filipits M
Mol Imaging Biol; 2019 Oct; 21(5):991-1002. PubMed ID: 30652258
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable β-catenin Overexpression and a β-catenin Mutation.
Birkeland AC; Burgin SJ; Yanik M; Scott MV; Bradford CR; McHugh JB; McLean SA; Sullivan SE; Nor JE; McKean EL; Brenner JC
J Neurol Surg B Skull Base; 2017 Aug; 78(4):346-352. PubMed ID: 28725522
[No Abstract] [Full Text] [Related]
16. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
Bonazzoli E; Cocco E; Lopez S; Bellone S; Zammataro L; Bianchi A; Manzano A; Yadav G; Manara P; Perrone E; Haines K; Espinal M; Dugan K; Menderes G; Altwerger G; Han C; Zeybek B; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2019 Apr; 153(1):158-164. PubMed ID: 30630630
[TBL] [Abstract][Full Text] [Related]
17. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
[TBL] [Abstract][Full Text] [Related]
18. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
[TBL] [Abstract][Full Text] [Related]
19. Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1.
Choy E; MacConaill LE; Cote GM; Le LP; Shen JK; Nielsen GP; Iafrate AJ; Garraway LA; Hornicek FJ; Duan Z
PLoS One; 2014; 9(7):e101283. PubMed ID: 24983247
[TBL] [Abstract][Full Text] [Related]
20. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
